Mariola Fotin-Mleczek

Mariola Fotin-Mleczek, PhD
Chief Technology Officer
trained in biology at the University of Stuttgart. Her scientific expertise includes immunology, cell biology, signal transduction, apoptosis and cellular uptake. She joined CureVac in Mai 2006 when she was responsible for the development and preclinical testing of RNActive® cancer vaccines. She is inventor of RNActive® related key patents and she authored several publications on mRNA technology